Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Aduro Biotech (ADRO)

6.85 -0.1 (-1.44%)

04-24 16:00

Open:

6.95

Pre. Close:

6.95

High:

7.05

Low:

6.75

Volume:

267,924

Market Cap:

538M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

7.066 - 7.101

7.101 - 7.129

Low:

6.656 - 6.702

6.702 - 6.74

Close:

6.785 - 6.855

6.855 - 6.913

Technical analysis  (as of: 2018-04-24 4:22:14 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 10.12     One year: 11.50

Support:

Support1: 6.75    Support2: 5.62

Resistance:

Resistance1: 8.67    Resistance2: 9.85

Pivot:

7.53

Moving Averages:

MA(5): 6.99     MA(20): 7.91

MA(100): 7.59     MA(250): 9.40

MACD:

MACD(12,26): -0.34     Signal(12,26,9): -0.18

%K %D:

%K(14,3): 7.02     %D(3): 7.30

RSI:

RSI(14): 32.76

52-Week:

High: 14.05  Low: 5.825  Change(%): -29.0

Average Vol(K):

3-Month: 61243  10-Days 47331

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ADRO has closed above bottom band by 18.4%. Bollinger Bands are 19.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-21T08:00:00-04:00
3 Things In Biotech, April 20: AstraZeneca Re-Enters The Big Leagues, Aduro Looks Ahead, Lilly Looks Close

2018-04-10T12:20:58-04:00
Aduro Biotech (ADRO) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow

2018-04-06T07:14:53-04:00
Key events next week - healthcare

2018-03-16T10:26:29-04:00
Key events next week - healthcare (continued #1)

2018-03-15T13:32:34-04:00
Aduro Biotech (ADRO) Presents At 38th Annual Cowen and Company Healthcare Conference - Slideshow

2018-03-07T08:00:00-05:00
Your Daily Pharma Scoop: Genocea Surges, Gilead's Biktarvy, GlaxoSmithKline's Vaccine Succeeds In Late-Stage Study

2018-03-01T16:04:09-05:00
Aduro Biotech beats by $0.02, misses on revenue

2018-02-22T08:46:38-05:00
Premarket analyst action - healthcare

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

81.01

Shares Float (M)

79.81

% Held by Insiders

1.50

% Held by Institutions

67.30

Shares Short (K)

6436

Shares Short Prior Month (K)

5810

Stock Financials

EPS

-1.270

EPS Est. Current Year

-1.350

EPS Est. Next Year

-1.270

EPS Est. Next Quarter

-0.380

Forward EPS

-1.211

Book Value (p.s.)

2.420

PEG Ratio

4.75

Profit Margin

Operating Margin

-617.51

Return on Assets (ttm)

-20.8

Return on Equity (ttm)

-39.5

Qtrly Rev. Growth

-3.1

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.931

Qtrly Earnings Growth

Operating Cash Flow (M)

-88.86

Levered Free Cash Flow (M)

-57.25

atoplab.com

Valuation

P/E

-5.39

P/E Growth Ratio

-0.01

P/BV

2.83

P/S

2312160256.00

P/CF

-6.24

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.